Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer-Reference-Cited by-同舟云学术

Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer

Published:2018-12-25 Issue:101 Volume:9 Page:37520-37533
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Shintani Takuya¹²,Higashisaka Kazuma¹³,Maeda Makiko¹,Hamada Masaya¹,Tsuji Ryosuke¹,Kurihara Koudai¹,Kashiwagi Yuri¹,Sato Atsuhiro¹,Obana Masanori¹,Yamamoto Ayaha¹,Kawasaki Keisuke⁴,Lin Ying¹,Kijima Takashi⁵⁶,Kinehara Yuhei⁶,Miwa Yoshihiro²,Maeda Shinichiro¹²,Morii Eiichi⁴,Kumanogoh Atsushi⁶⁷,Tsutsumi Yasuo¹⁸,Nagatomo Izumi⁶,Fujio Yasushi¹⁷

Affiliation:

1. Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan

2. Department of Pharmacy, Osaka University Hospital, Suita, Japan

3. Department of Legal Medicine, Osaka University Graduate School of Medicine, Suita, Japan

4. Department of Pathology, Osaka University Graduate School of Medicine, Suita, Japan

5. Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan

6. Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Japan

7. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Japan

8. The Center for Advanced Medical Engineering and Informatics, Osaka University, Suita, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Mechanisms underlying Aortic Dissection: A Preliminary Bioinformatics Analysis of Signal Pathways and Hub Genes;Vascular Failure;2023-12-01

2. The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2023-03-02

3. Progesterone receptor membrane component 2 expression leads to erlotinib resistance in lung adenocarcinoma cells;PHARMAZIE;2021

4. Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma;Digestive Diseases and Sciences;2021-02-12

5. Identification of MMP1 as a potential gene conferring erlotinib resistance in non-small cell lung cancer based on bioinformatics analyses;Hereditas;2020-07-23